Health Care: Drugs

Theravance Inc (THRX: NASDAQ)

$15.9 -0.03 | -0.19%
09/04/15 - 12:47 PM ET
Company Profile
Price and Volume
Recent Price 15.93
52 Week High 21.25
52 Week Low 10.58
Avg. Daily Vol. (Mil) 0.57
Beta (3 year) 2.70
Share Related Items
Mkt Cap (Mil) 1,865.87
Shares Out (Mil) 117.13
Float (Mil) 32.98
Dividend Information
Yield % 6.30
Annual Dividend 1.00
Payout Ratio n.a.
Financial Strength
Quick Ratio 19.90
Current Ratio 20.00
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 72.24
Price/Book 0.00
Price/Cash Flow -49.00
Per Share Data
Earnings -0.48
Sales 0.22
Book Value 0.00
Cash Flow -0.32
Business Summary
Theravance Inc provides is a royalty management company engaged in maximizing the potential value of the respiratory assets.
General Information
901 Gateway Boulevard
South San Francisc, CA 94080
www.theravance.com
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Michael W. Aguiar
Short Interest
Current Month (Mil) 26.88
Previous Month (Mil) 26.19
Short Interest Ratio (Days) 53.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -12.00
Return on Investments -12.50
Profitability
Gross Margin n.a.
EBIT Margin -88.80
Profit Margin 0.00

Portfolios with THRX

Latest THRX Headlines from TheStreet

More Financial News for THRX

Press Releases for THRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter